US 12,440,473 B2
Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain
Stephanie Venn-Watson, San Diego, CA (US)
Assigned to Epitracker, Inc., San Diego, CA (US)
Filed by Epitracker, Inc., San Diego, CA (US)
Filed on Aug. 30, 2021, as Appl. No. 17/461,325.
Application 17/461,325 is a continuation of application No. PCT/US2020/020697, filed on Mar. 2, 2020.
Claims priority of provisional application 62/824,247, filed on Mar. 26, 2019.
Claims priority of provisional application 62/813,566, filed on Mar. 4, 2019.
Prior Publication US 2021/0386710 A1, Dec. 16, 2021
Int. Cl. A61K 31/41 (2006.01); A61K 31/20 (2006.01); A61P 3/00 (2006.01)
CPC A61K 31/41 (2013.01) [A61K 31/20 (2013.01); A61P 3/00 (2018.01)] 22 Claims
 
1. A method of treatment of a condition selected from the group consisting of impaired cognition, movement disorders, chronic pain, depression, decreased appetite, convulsion, seizure, anorexia, cachexia, and addiction, comprising:
administering to a patient in need thereof, a pharmaceutical composition comprising an effective amount of a compound having a structure selected from the group consisting of:

OG Complex Work Unit Chemistry
and pharmaceutically acceptable salts thereof.